HomeNews

News

R21/Matrix-M Malaria Vaccine Discovery: Paving the Way for a Malaria-Free Future

Global health
Health
Malaria
Vaccines
New trial to study how the human immune system adapts to ‘tolerate’ malaria parasites

New trial to study how the human immune system adapts to ‘tolerate’ malaria parasites

Global health
Malaria
Vaccines
Mosquito

Antimalarial treatments more likely to fail in children with acute malnutrition

Global health
Malaria
Medical Sciences
Research
New Phase 3 Trial Data Confirm the Uniquely High Efficacy and Good Safety Profile of the R21/Matrix-M Malaria Vaccine in African Children

New phase 3 trial data confirm the uniquely high efficacy and good safety profile of the R21/Matrix-M malaria vaccine in African children

Global health
Health
Malaria
Research
Vaccines
FCDO Minister meets with University of Oxford’s vaccine researchers

FCDO Minister meets with University of Oxford’s vaccine researchers

COVID-19 vaccine
Funding
Global health
Malaria
Research
Vaccines
African doctor and malaria vaccine

Oxford R21/Matrix-M™ malaria vaccine receives WHO recommendation for use paving the way for global roll-out

Malaria
Medical Sciences
Research
Vaccines
Burkina Faso R21 vaccine regulatory clearance

Oxford R21/Matrix-M™ malaria vaccine receives regulatory clearance for use in Burkina Faso

Health
Malaria
Vaccines
R21 vaccinations at Tanzania clinical site,Tom Wilkinson, University of Oxford

R21/Matrix-M™ malaria vaccine developed by University of Oxford receives regulatory clearance for use in Ghana

Malaria
Medical Sciences
Research
Vaccines
A child is vaccinated with the R21 malaria vaccine at Nanoro, Burkina Faso - credit Prof Katie Ewer

Malaria booster vaccine continues to meet WHO-specified 75% efficacy goal

Malaria
Research
Vaccines
Anopheles mosquito

Reducing children’s exposure to malaria in their early years substantially cuts the risk of hospitalisation.

Health
Malaria
Mathematical, Physical and Life Sciences
Research

Pages